Archives of Clinical Infectious Diseases

Published by: Kowsar

The Impact of Mutations in Topoisomerase Genes and the Plasmid-Mediated Quinolone Resistance (PMQR) Determinants on the Resistance to Fluoroquinolones in Klebsiella pneumoniae

Alisha Akya 1 , Roya Chegene Lorestani 2 , * , Azam Elahi 2 and Keyghobad Ghadiri 3
Authors Information
1 Nosocomial Infections Research Center, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
2 Department of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
3 Nosocomial Infections Research Center, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: October 2017, 12 (4); e57290
  • Published Online: April 26, 2017
  • Article Type: Research Article
  • Received: August 21, 2016
  • Revised: February 11, 2017
  • Accepted: February 12, 2017
  • DOI: 10.5812/archcid.57290

To Cite: Akya A, Chegene Lorestani R, Elahi A, Ghadiri K. The Impact of Mutations in Topoisomerase Genes and the Plasmid-Mediated Quinolone Resistance (PMQR) Determinants on the Resistance to Fluoroquinolones in Klebsiella pneumoniae, Arch Clin Infect Dis. 2017 ;12(4):e57290. doi: 10.5812/archcid.57290.

Abstract
Copyright © 2017, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Sahly H, Podschun R. Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelae. Clin Diagn Lab Immunol. 1997;4(4):393-9. [PubMed: 9220153].
  • 2. Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012;27(2):128-42. doi: 10.3904/kjim.2012.27.2.128. [PubMed: 22707882].
  • 3. Sarkozy G. Quinolone:a class of antimicrobial agents. J Vet Med. 2001;46(9-10):257-74.
  • 4. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis. 2001;7(2):337-41. doi: 10.3201/eid0702.700337. [PubMed: 11294736].
  • 5. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003;51(5):1109-17. doi: 10.1093/jac/dkg222. [PubMed: 12697644].
  • 6. Ambrozic Avgustin J, Keber R, Zerjavic K, Orazem T, Grabnar M. Emergence of the quinolone resistance-mediating gene aac(6')-Ib-cr in extended-spectrum-beta-lactamase-producing Klebsiella isolates collected in Slovenia between 2000 and 2005. Antimicrob Agents Chemother. 2007;51(11):4171-3. doi: 10.1128/AAC.01480-06. [PubMed: 17846136].
  • 7. Zibaei M, Firoozeh F. Detection of qnrA gene among quinolone-resistant Escherichia coli isolated from urinary tract infections in Khorram Abad during 2011-2012. KAUMS J. 2013;17(5):488-94.
  • 8. Hooper DC. Mechanisms of quinolone resistance. In: Hooper DC, Rubenstein E, editors. Quinolone antimicrobial agents. Washington: American Society for Microbiology Press; 2003. p. 41-67.
  • 9. El-Sokkary MMA, Abdelmegeed ES. Antibacterial resistance pattern among Escherichia coli strains isolated from Mansoura hospitals in Egypt with a special reference to quinolones. Afr J Microbiol Res. 2015;9(9):662-70.
  • 10. Ito CA, Gales AC, Tognim MC, Munerato P, Dalla Costa LM. Quinolone-resistant Escherichia coli. Braz J Infect Dis. 2008;12(1):5-9. [PubMed: 18553006].
  • 11. De la Fuente CM, Dauros SP, Bello TH, Dominguez YM, Mella MS, Sepulveda AM, et al. [Mutations in gyrA and gyrB genes among strains of Gram-negative bacilli isolated from Chilean hospitals and their relation with resistance to fluoroquinolones]. Rev Med Chil. 2007;135(9):1103-10. [PubMed: 18064363].
  • 12. Gharib AA, El-Aziz NKA. Molecular an analysis of quinolone resistance-determining regions in avian pathogenic Escherichia coli. Int J Adv Res. 2013;1:145-57.
  • 13. Al-Marzooq F, Mohd Yusof MY, Tay ST. Molecular analysis of ciprofloxacin resistance mechanisms in Malaysian ESBL-producing Klebsiella pneumoniae isolates and development of mismatch amplification mutation assays (MAMA) for rapid detection of gyrA and parC mutations. Biomed Res Int. 2014;2014:601630. doi: 10.1155/2014/601630. [PubMed: 24860827].
  • 14. Kang HY, Tamang MD, Seol SY, Kim J. Dissemination of Plasmid-mediated qnr, aac(6')-Ib-cr, and qepA Genes Among 16S rRNA Methylase Producing Enterobacteriaceae in Korea. J Bacteriol Virol. 2009;39(3):173. doi: 10.4167/jbv.2009.39.3.173.
  • 15. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006;50(11):3953-5. doi: 10.1128/AAC.00915-06. [PubMed: 16954321].
  • 16. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 2007;51(9):3354-60. doi: 10.1128/AAC.00339-07. [PubMed: 17548499].
  • 17. Performance standards for antimicrobial susceptibility testing. Wayne: Clinical and Laboratory Standards Institute; 2011.CLSI informational supplement.
  • 18. Weigel LM, Steward CD, Tenover FC. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob Agents Chemother. 1998;42(10):2661-7. [PubMed: 9756773].
  • 19. Paltansing S, Kraakman M, Ras JMC, Wessels E, Bernards AT. Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE. J Antimicrob Chemother. 2012;68(1):40-5.
  • 20. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006;50(8):2872-4. doi: 10.1128/AAC.01647-05. [PubMed: 16870791].
  • 21. Fu Y, Zhang W, Wang H, Zhao S, Chen Y, Meng F, et al. Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli. BMC Infect Dis. 2013;13:8. doi: 10.1186/1471-2334-13-8. [PubMed: 23295059].
  • 22. Morgan-Linnell SK, Becnel Boyd L, Steffen D, Zechiedrich L. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob Agents Chemother. 2009;53(1):235-41. doi: 10.1128/AAC.00665-08. [PubMed: 18838592].
  • 23. Frank T, Mbecko JR, Misatou P, Monchy D. Emergence of quinolone resistance among extended-spectrum beta-lactamase-producing Enterobacteriaceae in the Central African Republic: genetic characterization. BMC Res Notes. 2011;4:309. doi: 10.1186/1756-0500-4-309. [PubMed: 21867486].
  • 24. Asadpour L. Study of Amino Acid Alteration in graA & parC Genes in Quinolone Resistant Klebsiella pnemoniae. Crescent J Med Biol Sci. 2016;4(1).
  • 25. Willmott CJ, Maxwell A. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob Agents Chemother. 1993;37(1):126-7. doi: 10.1128/aac.37.1.126.
  • 26. Al-Agamy MHM, Shibl AM, Radwan HH. Detection of mutations in quinolone-resistant determining regions in clinical isolates of Escherichia coli from Saudi Arabia. Afr J Biotechnol. 2012;11(5):1054-8.
  • 27. Heisig P, Schedletzky H, Falkenstein-Paul H. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob Agents Chemother. 1993;37(4):696-701. [PubMed: 8388197].
  • 28. Vila J, Ruiz J, Marco F, Barcelo A, Goni P, Giralt E, et al. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother. 1994;38(10):2477-9. [PubMed: 7840592].
  • 29. Deguchi T, Fukuoka A, Yasuda M, Nakano M, Ozeki S, Kanematsu E, et al. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1997;41(3):699-701. [PubMed: 9056017].
  • 30. Drago L, Nicola L, Mattina R, De Vecchi E. In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations. BMC Microbiol. 2010;10:119. doi: 10.1186/1471-2180-10-119. [PubMed: 20409341].
  • 31. Park DJ, Yu JK, Park KG, Park YJ. Genotypes of ciprofloxacin-resistant Klebsiella pneumoniae in Korea and their characteristics according to the genetic lineages. Microb Drug Resistance. 2015;21(6):622-30.
  • 32. Eftekhar F, Seyedpour S. Prevalence of qnr and aac(6')-Ib-cr Genes in Clinical Isolates of Klebsiella Pneumoniae from Imam Hussein Hospital in Tehran. Iran J Med Sci. 2015;40(6):515-21. [PubMed: 26538780].
  • 33. Yang HY, Nam YS, Lee HJ. Prevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in Korea. Can J Infect Dis Med Microbiol. 2014;25(3):163-9. [PubMed: 25285114].
  • 34. Karah N, Poirel L, Bengtsson S, Sundqvist M, Kahlmeter G, Nordmann P, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. Diagn Microbiol Infect Dis. 2010;66(4):425-31. doi: 10.1016/j.diagmicrobio.2009.12.004. [PubMed: 20226333].
  • 35. Jiang Y, Zhou Z, Qian Y, Wei Z, Yu Y, Hu S, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother. 2008;61(5):1003-6. doi: 10.1093/jac/dkn063. [PubMed: 18299311].
  • 36. Pasom W, Chanawong A, Lulitanond A, Wilailuckana C, Kenprom S, Puang-Ngern P. Plasmid-mediated quinolone resistance genes, aac(6')-Ib-cr, qnrS, qnrB, and qnrA, in urinary isolates of Escherichia coli and Klebsiella pneumoniae at a teaching hospital, Thailand. Jpn J Infect Dis. 2013;66(5):428-32. [PubMed: 24047744].
  • 37. Saiful Anuar AS, Mohd Yusof MY, Tay ST. Prevalence of plasmid-mediated qnr determinants and gyrase alteration in Klebsiella pneumoniae isolated from a university teaching hospital in Malaysia. Eur Rev Med Pharmacol Sci. 2013;17(13):1744-7. [PubMed: 23852897].
  • 38. Shams E, Firoozeh F, Moniri R, Zibaei M. Prevalence of plasmid-mediated quinolone resistance genes among extended-spectrum β-Lactamase-producing Klebsiella pneumoniae human isolates in Iran. J Pathogens. 2015;2015.
  • 39. Alheib O, Al Kayali R, Abajy MY. Prevalence of Plasmid-Mediated Quinolone Resistance (PMQR) Determinants Among Extended Spectrum Beta-Lactamases (ESBL)-Producing Isolates of Escherichia coli and Klebsiella pneumoniae in Aleppo, Syria. Arch Clin Infect Dis. 2015;10(3). doi: 10.5812/archcid.20631.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments